Keyphrases
Obesity
59%
Adipose-derived Stromal Cells
47%
Tumor
44%
Tumor Microenvironment
39%
COP9 Signalosome
39%
Microenvironment
39%
Muscle Stem Cell (MuSC)
27%
Skeletal muscle
25%
Adipose Tissue
22%
Cell Trafficking
21%
Adipocyte
21%
Cell Function
21%
Pan-ERBB Inhibitor
19%
P57Kip2
19%
Green Fluorescent Protein
19%
MEK Inhibitor (MEKi)
19%
Progeria Syndrome
19%
Mutation Mutation
19%
Parabiotic
19%
Phase I Trial
19%
Healthy Mice
19%
EGFR mutation
19%
BRCA1, BRCA2
19%
Neddylation
19%
CDK Inhibitors
19%
Platelet-derived Growth Factor Receptor (PDGFR)
19%
Cullin
19%
Oncogenesis
19%
Aging
19%
Cell Cycle Regulators
19%
Duchenne muscular Dystrophy
19%
Muscular Dystrophy
19%
Cellular Factors
19%
Muscle Pathology
19%
HER3
19%
Trametinib
19%
Skeletal muscle Repair
19%
Talazoparib
19%
Circulating Factors
19%
Myogenic Progenitor Cells
19%
HER2 mutation
19%
Secreted Protein Acidic and Rich in Cysteine
19%
Pericytes
19%
CXCL1
19%
Regenerative Responses
19%
DNA Repair
19%
Cancer Metabolic Reprogramming
19%
Neratinib
19%
Patients with Advanced Cancer
19%
Tissue Imaging
19%
Biochemistry, Genetics and Molecular Biology
Progenitor Cell
100%
Stromal Cell
88%
COP9 Signalosome
45%
Adipocyte
44%
Skeletal Muscle
41%
Tumor Progression
31%
Cell Cycle
29%
Cell Function
28%
Ubiquitination
25%
Cell Growth
24%
Vascularization
23%
Cell Migration
23%
Parabiosis
22%
Platelet-Derived Growth Factor Receptor
22%
Myc
19%
Reprogramming
19%
Pericyte
19%
Carcinogenesis
19%
Peptide Library
19%
DNA Repair
19%
Osteonectin
19%
Cyclin-Dependent Kinase
19%
Drive
19%
Hypoxia Inducible Factor 1
19%
CXCL1
19%
Innate Immunity
19%
Rigidity
19%
Isoform
19%
Progeria
19%
Green Fluorescent Protein
19%
BRCA1
19%
Infrared Radiation
19%
Ubiquitin-Conjugating Enzyme
19%
Cytoskeleton
19%
Cullin
17%
Stem Cell
17%
P53
16%
Ubiquitin Ligase
15%
Cancer Cell
14%
Cell Proliferation
14%
Mouse Model
14%
Cell Survival
13%
Muscle Regeneration
13%
Wild Type Mouse
11%
Dystrophin
11%
Programmed Cell Death
11%
Gene Expression
10%
Poly ADP Ribose Polymerase
9%
Steady State
9%
Metabolic Pathway
9%
Medicine and Dentistry
Adipose Tissue
39%
Stromal Cell
29%
Tumor Progression
29%
Progenitor Cell
29%
Neoplasm
29%
Tumor Microenvironment
24%
Adipocyte
22%
White Adipose Tissue
22%
BRCA1
19%
Muscle Disease
19%
Progeria
19%
Talazoparib
19%
Innate Immunity
19%
Pericyte
19%
Cytoskeleton
19%
DNA Repair
19%
Muscular Dystrophy
19%
Advanced Cancer
19%
Histopathology
19%
Cellular Senescence
19%
Green Fluorescent Protein
14%
Malignant Neoplasm
14%
Duchenne Muscular Dystrophy
14%
PARP Inhibitor
9%
Mesenchymal Stem Cell
9%
Progerin
5%
Micronucleus
5%